A Case study on Ayurvedic management of Deviated nasal septum
DOI:
https://doi.org/10.70066/jahm.v12i5.1364Keywords:
Chronic sinusitis ,Deviated nasal septum, , Nasanaah, Peenasam, Viddha, SNOT-22 (Sino Nasal Outcome Test-22)Abstract
Deviated nasal septum(DNS) is a relatively prevalent disorder that can cause obstructive sleep apnea, migraine, sinusitis, epistaxis, and nasal blockage in moderate to severe cases. Patients suffering from DNS switch to alternate therapies due to return of symptoms. Peenasam or Nasanaah resembles the clinical signs of DNS. Our study's objective was to ascertain whether traditional Viddha karma can serve as an additional therapeutic option in case of DNS by lowering the patients' current symptoms, medication dependence without the need of surgery for relief of symptoms. Viddha Karma has been used to cure adults for symptoms brought on by DNS ,sinusitis, hypertrophied turbinates .This article describes a 16-year-old male patient who had three Viddha sessions over the course of a week on alternate days for his hypertrophied turbinates and deviated nasal septum. The Snot-22 questionnaire and lab investigations showed improvement. The functional outcome was achieved in patient along with Nasya and some Ayurvedic medicines. Viddha karma, along with Nasya and Ayurvedic medicines has been shown to be highly effective in treating symptoms.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 SHEETAL SONWANE SHEETAL, KAVITA FADNAVIS, KAVITA FADNAVIS

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.